Financial News
Press Releases about Takeda Pharmaceutical Ltd ADR
![](https://mms.businesswire.com/media/20220530005448/en/834514/4/takeda_logo.jpg)
![](https://storage.googleapis.com/accesswire/logos/share/8322.png?v=1)
![](https://mms.businesswire.com/media/20220525005958/en/694986/4/3472696_BrandSymbol_Dakiyama_Rd.jpg)
![](https://www.3blmedia.com/sites/www.3blmedia.com/files/images/Takeda111021A.jpeg)
![](https://mms.businesswire.com/media/20220510006534/en/791321/5/logo.jpg)
![](https://mms.businesswire.com/media/20220426005347/en/1432029/5/Dakiyama_2021_Takeda_Red_DIGITAL_%281%29.jpg)
![](https://mms.businesswire.com/media/20220422005076/en/1247790/5/Takeda_Red_Logo_2021.jpg)
![](https://mms.businesswire.com/media/20220418005475/en/1423565/5/Takeda_Logo_Hi_Res.jpg)
![](https://mms.businesswire.com/media/20220418005108/en/1247790/5/Takeda_Red_Logo_2021.jpg)
Exposures
COVID-19
![](https://mms.businesswire.com/media/20220412006189/en/791321/5/logo.jpg)
![](https://mms.businesswire.com/media/20220412005305/en/694986/4/3472696_BrandSymbol_Dakiyama_Rd.jpg)
![](https://mms.businesswire.com/media/20220405005028/en/1406878/5/nyas-logo.jpg)
![](https://mms.businesswire.com/media/20220328005150/en/694986/4/3472696_BrandSymbol_Dakiyama_Rd.jpg)
![](https://mms.businesswire.com/media/20220228005184/en/1247790/5/Takeda_Red_Logo_2021.jpg)
![](https://mms.businesswire.com/media/20220217005625/en/731159/5/TakedaBrandSymbol_Dakiyama_Rd.jpg)
![](https://mms.businesswire.com/media/20220202006050/en/1348379/5/Dakiyama_2021_Red_DIGITAL_%282%29.jpg)
![](https://mms.businesswire.com/media/20220131005214/en/694986/4/3472696_BrandSymbol_Dakiyama_Rd.jpg)
![](https://mms.businesswire.com/media/20220119005654/en/1332572/5/Dakiyama_2021_Takeda_Red_DIGITAL_USE.jpg)
Takeda Named Global Top Employer for Fifth Consecutive Year
January 19, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220110005102/en/1321848/5/Dakiyama_2021_Takeda_Red_DIGITAL_USE.jpg)
![](https://mms.businesswire.com/media/20220110005824/en/1323512/5/Dakiyama_2021_Red_DIGITAL.jpg)
![](https://mms.businesswire.com/media/20211221005772/en/1313118/5/Dakiyama_2021_Red_DIGITAL-01.jpg)
Systemic Mastocytosis Treatments Gain Hope Due To Increasing Novel Treatment Options
December 21, 2021
Exposures
Product Safety
![](https://mms.businesswire.com/media/20211213005174/en/1247790/5/Takeda_Red_Logo_2021.jpg)
![](https://mms.businesswire.com/media/20211208005325/en/1247790/5/Takeda_Red_Logo_2021.jpg)
![](https://mms.businesswire.com/media/20211207005371/en/822613/5/takeda_logo.jpg)
![](https://mms.businesswire.com/media/20211202005653/en/932312/5/LIVTENCITY_TM_Logo_Pos_RGB.jpg)
![](https://mms.businesswire.com/media/20211130005237/en/931165/5/Dakiyama_2021_Takeda_Red_DIGITAL_USE.jpg)
![](https://mms.businesswire.com/media/20211123006185/en/930131/5/Dakiyama_2021_Takeda_Red_DIGITAL.jpg)
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.